Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis) Trial

NCT00574691 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT00574691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00574691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis) Trial
Lead sponsor
Cordis US Corp.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2007
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, transluminal, percutaneous coronary, coronary arteriosclerosis